Who We HelpOur ScienceProductsOutcomes
Log InAskSequence your genome↗
Traits
Traits linked to MT-ND3
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 3
The Human Phenotype Ontology links 81 traits to MT-ND3, by body system: features seen in people with one of the gene's rare conditions.
Who We HelpOur ScienceProductsOutcomes
Log InAskSequence your genome↗
Who We HelpOur ScienceProductsOutcomes
Log InAskSequence your genome↗
Abnormality of the nervous system
Laboratory abnormality
| Trait | How often it is seen |
|---|---|
| Abnormality of Krebs cycle metabolism | Very often (80–99%) |
| Increased circulating pyruvate concentration | Very often (80–99%) |
| Increased CSF lactate | Very often (80–99%) |
| Increased lactate in body | Very often (80–99%) |
| Low blood sugar | Very often (80–99%) |
| High urine lactic acid levels | Often (30–79%) |
| Higher than normal levels of lactate in blood | Often (30–79%) |
| Diabetes mellitus | Sometimes (5–29%) |
| Fever | Sometimes (5–29%) |
| Hypothermia | Sometimes (5–29%) |
| Increased blood alanine | Sometimes (5–29%) |
| Decreased circulating citrulline concentration | Rarely (1–4%) |
Abnormality of the eye
| Trait | How often it is seen |
|---|---|
| Cross-eyed | Very often (80–99%) |
| Damaged optic nerve | Very often (80–99%) |
| Drooping upper eyelid | Very often (80–99%) |
| Involuntary, rapid, rhythmic eye movements | Very often (80–99%) |
| Optic disc pallor | Very often (80–99%) |
| Paroxysmal involuntary eye movements | Very often (80–99%) |
| Pigmentary retinopathy | Often (30–79%) |
| Weakness of muscles controlling eye movement | Often (30–79%) |
| Blindness | Sometimes (5–29%) |
| Optic atrophy | Sometimes (5–29%) |
| Rod-cone dystrophy | Sometimes (5–29%) |
Abnormality of the musculoskeletal system
| Trait | How often it is seen |
|---|---|
| Low muscle tone | Very often (80–99%) |
| Mitochondrial myopathy | Very often (80–99%) |
| Muscle weakness | Very often (80–99%) |
| Poor head control | Very often (80–99%) |
| Decreased muscle tone in infant | Often (30–79%) |
| Involuntary muscle stiffness, contraction, or spasm | Often (30–79%) |
| Spasticity and rigidity of muscles | Often (30–79%) |
| Ragged-red muscle fibers | Rarely (1–4%) |
Abnormality of the digestive system
| Trait | How often it is seen |
|---|---|
| Enlarged liver | Very often (80–99%) |
| Vomiting | Very often (80–99%) |
| Episodic vomiting | Often (30–79%) |
| Feeding difficulties | Sometimes (5–29%) |
| Liver failure | Sometimes (5–29%) |
| Poor swallowing | Sometimes (5–29%) |
Abnormality of the respiratory system
| Trait | How often it is seen |
|---|---|
| Respiratory function loss | Very often (80–99%) |
| Apnea | Sometimes (5–29%) |
| Breathing difficulty | Sometimes (5–29%) |
| Episodic difficulty breathing | Sometimes (5–29%) |
| Rapid breathing | Sometimes (5–29%) |
Abnormality of the cardiovascular system
| Trait | How often it is seen |
|---|---|
| Enlarged and thickened heart muscle | Very often (80–99%) |
| Cardiac conduction abnormality | Sometimes (5–29%) |
| Stretched and thinned heart muscle | Sometimes (5–29%) |
Abnormality of the genitourinary system
| Trait | How often it is seen |
|---|---|
| Proximal tubulopathy | Very often (80–99%) |
| Abnormal renal tubule morphology | Sometimes (5–29%) |
| Multiple glomerular cysts | Sometimes (5–29%) |
Abnormal cellular phenotype
| Trait | How often it is seen |
|---|---|
| Decreased activity of mitochondrial complex I | Always |
| Abnormal mitochondria in muscle tissue | Very often (80–99%) |
Growth abnormality
| Trait | How often it is seen |
|---|---|
| Faltering weight | Very often (80–99%) |
| Prenatal growth deficiency | Very often (80–99%) |
Abnormality of head or neck
| Trait | How often it is seen |
|---|---|
| Abnormally small head | Sometimes (5–29%) |
Abnormality of prenatal development or birth
| Trait | How often it is seen |
|---|---|
| Fetal distress | Sometimes (5–29%) |
Abnormality of the ear
| Trait | How often it is seen |
|---|---|
| Sensorineural hearing impairment | Very often (80–99%) |
How often is among people with one of the gene's conditions, the most often across them, as the Human Phenotype Ontology records it. These pages describe traits and the research behind them; they are not a diagnosis, and a doctor or genetic counsellor is the person to ask about symptoms.
Where this comes from
- The Human Phenotype Ontology, release 2026-09-01: the traits linked to MT-ND3 and how often each is seen. Find out more at hpo.jax.org.
Who We HelpOur ScienceProductsOutcomes
Log InAskSequence your genome↗
One test. A lifetime of answers.
From $449Free shipping · Results in 6–8 weeks